Back to Search
TAYLOR J BRUESEKE MD
MD
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
NPI: 1821304882IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology Physician
Obstetrics & Gynecology
Code: 207V00000X
A121053(CA)
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianPrimary
Obstetrics & Gynecology — Urogynecology and Reconstructive Pelvic Surgery
Code: 207VF0040X
A121053(CA)
Education
OTHER
Class of 2010
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (14)
Outcomes of a single trigone-only vs. 20 trigone-sparing injections of OnabotulinumtoxinA for refractory overactive bladder (OAB).
PMID 33742316·Int Urol Nephrol·2021
4-observational
Less is more-A pilot study evaluating one to three intradetrusor sites for injection of OnabotulinumtoxinA for neurogenic and idiopathic detrusor overactivity.
PMID 27283922·Neurourol Urodyn·2017
8-other
Different number of intravesical onabotulinumtoxinA injections for patients with refractory detrusor overactivity do not affect treatment outcome: A prospective randomized comparative study.
PMID 25914349·Neurourol Urodyn·2016
4-observational
OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial.
PMID 27701661·JAMA·2016
4-observational
OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.
PMID 23246476·J Urol·2013
3-trial
OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
PMID 23608668·Eur Urol·2013
3-trial
Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence.
PMID 23036134·N Engl J Med·2012
4-observational
Spread of onabotulinumtoxinA after bladder injection. Experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action.
PMID 22306320·Eur Urol·2012
7-preclinical
A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging.
PMID 19145439·World J Urol·2009
8-other
Refractory idiopathic urge urinary incontinence and botulinum A injection.
PMID 18499184·J Urol·2008
4-observational
Effects of cholesterol on physical properties of human erythrocyte membranes: impact on susceptibility to hydrolysis by secretory phospholipase A2.
PMID 18192373·Biophys J·2008
8-other
Use of fluorescence to determine the effects of cholesterol on lipid behavior in sphingomyelin liposomes and erythrocyte membranes.
PMID 18299615·J Lipid Res·2008
8-other
Relationship between membrane physical properties and secretory phospholipase A2 hydrolysis kinetics in S49 cells during ionophore-induced apoptosis.
PMID 17545239·Biophys J·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 101 THE CITY DR S
ORANGE, CA 92868 - Phone
- (714) 456-2911
Quick Facts
- NPI
- 1821304882
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 16
- Clinical Trials
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile